Margarita Ivanova, PhD
Director of Translational Research Unit
Research interests are at the intersection of lysosomal storage disorders, new biomarkers development, and novel therapies. One focus area is the development and implementation of individual screening of novel therapies for patients with rare genetic diseases. My studies include many aspects of translational research utilizing experimental contributions to the fields of autophagy-lysosomal pathway, mitochondrial function, and sphingolipid metabolism.
Email: margarita.ivanova@ldrtc.org | mivanova@ldrtc.org
My PublicationsEmail: margarita.ivanova@ldrtc.org | mivanova@ldrtc.org
My Work
0
Publications
0
Reads
0
Citations
Recent Publications •
Neuronopathic Gaucher disease: Rare in the West, common in the East. J Inherit Metab Dis. 2024 Sep;47(5):917-934. doi: 10.1002/jimd.12749. Epub 2024 May 20. Review. PubMed PMID: 38768609.
The Expression and Secretion Profile of TRAP5 Isoforms in Gaucher Disease. Cells. 2024 Apr 20;13(8). doi: 10.3390/cells13080716. PubMed PMID: 38667330; PubMed Central PMCID: PMC11049511.
Biofabrication of anin-vitrobone model for Gaucher disease. Biofabrication. 2023 Sep 22;15(4). doi: 10.1088/1758-5090/acf95a. PubMed PMID: 37703870; PubMed Central PMCID: PMC10515412.
Circulated TGF-β1 and VEGF-A as Biomarkers for Fabry Disease-Associated Cardiomyopathy. Cells. 2023 Aug 19;12(16). doi: 10.3390/cells12162102. PubMed PMID: 37626912; PubMed Central PMCID: PMC10453505.